Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shaye B. Hagler"'
Autor:
Shaye B. Hagler, Juli R. Bagó, Morgan Goetz, Abigail G. Carey-Ewend, Hunter N. Bomba, Shawn Hingtgen
Publikováno v:
Tissue engineering. Part A. 27(13-14)
Engineered neural stem cells (NSCs) have recently emerged as a promising therapy. Acting as a tumor-homing drug-delivery system, NSCs migrate through brain tissue to seek out primary and invasive tumor foci. NSCs can deliver therapeutic agents, such
Autor:
Spencer M. Maingi, Andrew Buckley, Matthew G. Ewend, Simon Khagi, Juli R. Bagó, Shaye B. Hagler, Shawn Hingtgen, Vivien Lettry, C. Ryan Miller
Publikováno v:
Neuro Oncol
Induced neural stem-cells (iNSCs) represent a new opportunity in the emerging field of cellular immunotherapy. Patient-derived iNSCs modified to produce anti-tumoral compounds could lead to less rejection and safer outcomes than an off-the-shelf ther
Publikováno v:
Current Surgery Reports. 5
Emerging evidence has demonstrated that genetically engineered stem cells have unique tumor-homing capacity that allows them to deliver anticancer gene products directly into local and invasive glioblastoma foci. New clinical trials have been launche
Publikováno v:
Neuro-Oncology. 20:vi275-vi275
Tumor-homing neural stem cell (NSC) therapy is a promising new strategy that recently entered human patient testing for glioblastoma (GBM). The success of NSCs in the clinic will depend on their ability to overcome the heterogeneity and invasiveness
Autor:
Carey-Ewend, Abigail G., Hagler, Shaye B., Bomba, Hunter N., Goetz, Morgan J., Bago, Juli R., Hingtgen, Shawn D.
Publikováno v:
Tissue Engineering Part A: Tissue Engineering; Jul2021, Vol. 27 Issue 13/14, p857-866, 10p
Publikováno v:
Current Surgery Reports; Oct2017, Vol. 5 Issue 10, p1-14, 14p